280 related articles for article (PubMed ID: 38490949)
1. Deficits in olfactory system neurogenesis in neurodevelopmental disorders.
Sweat SC; Cheetham CEJ
Genesis; 2024 Apr; 62(2):e23590. PubMed ID: 38490949
[TBL] [Abstract][Full Text] [Related]
2. The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.
Juvale IIA; Che Has AT
J Mol Neurosci; 2021 Jul; 71(7):1338-1355. PubMed ID: 33774758
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders.
Benachenhou S; Laroui A; Dionne O; Rojas D; Toupin A; Çaku A
Int Rev Neurobiol; 2023; 173():115-139. PubMed ID: 37993175
[TBL] [Abstract][Full Text] [Related]
4. Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.
Boland MJ; Nazor KL; Tran HT; Szücs A; Lynch CL; Paredes R; Tassone F; Sanna PP; Hagerman RJ; Loring JF
Brain; 2017 Mar; 140(3):582-598. PubMed ID: 28137726
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive immunoprofiling of neurodevelopmental disorders suggests three distinct classes based on increased neurogenesis, Th-1 polarization or IL-1 signaling.
Sreenivas N; Maes M; Padmanabha H; Dharmendra A; Chakkera P; Paul Choudhury S; Abdul F; Mullapudi T; Gowda VK; Berk M; Vijay Sagar Kommu J; Debnath M
Brain Behav Immun; 2024 Jan; 115():505-516. PubMed ID: 37972879
[TBL] [Abstract][Full Text] [Related]
6. In vivo models to study neurogenesis and associated neurodevelopmental disorders-Microcephaly and autism spectrum disorder.
Prasad T; Iyer S; Chatterjee S; Kumar M
WIREs Mech Dis; 2023; 15(4):e1603. PubMed ID: 36754084
[TBL] [Abstract][Full Text] [Related]
7. Fragile X Mental Retardation Protein and Dendritic Local Translation of the Alpha Subunit of the Calcium/Calmodulin-Dependent Kinase II Messenger RNA Are Required for the Structural Plasticity Underlying Olfactory Learning.
Daroles L; Gribaudo S; Doulazmi M; Scotto-Lomassese S; Dubacq C; Mandairon N; Greer CA; Didier A; Trembleau A; Caillé I
Biol Psychiatry; 2016 Jul; 80(2):149-159. PubMed ID: 26372002
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal deficits in neurodevelopmental disorders.
Li Y; Shen M; Stockton ME; Zhao X
Neurobiol Learn Mem; 2019 Nov; 165():106945. PubMed ID: 30321651
[TBL] [Abstract][Full Text] [Related]
10. MeCP2 is required for activity-dependent refinement of olfactory circuits.
Degano AL; Park MJ; Penati J; Li Q; Ronnett GV
Mol Cell Neurosci; 2014 Mar; 59():63-75. PubMed ID: 24472844
[TBL] [Abstract][Full Text] [Related]
11. Understanding autism and other neurodevelopmental disorders through experimental translational neurobehavioral models.
Homberg JR; Kyzar EJ; Nguyen M; Norton WH; Pittman J; Poudel MK; Gaikwad S; Nakamura S; Koshiba M; Yamanouchi H; Scattoni ML; Ullman JF; Diamond DM; Kaluyeva AA; Parker MO; Klimenko VM; Apryatin SA; Brown RE; Song C; Gainetdinov RR; Gottesman II; Kalueff AV
Neurosci Biobehav Rev; 2016 Jun; 65():292-312. PubMed ID: 27048961
[TBL] [Abstract][Full Text] [Related]
12. A systematic-review of olfactory deficits in neurodevelopmental disorders: From mouse to human.
Lyons-Warren AM; Herman I; Hunt PJ; Arenkiel BR
Neurosci Biobehav Rev; 2021 Jun; 125():110-121. PubMed ID: 33610612
[TBL] [Abstract][Full Text] [Related]
13. Neuron-Specific FMRP Roles in Experience-Dependent Remodeling of Olfactory Brain Innervation during an Early-Life Critical Period.
Golovin RM; Vest J; Broadie K
J Neurosci; 2021 Feb; 41(6):1218-1241. PubMed ID: 33402421
[TBL] [Abstract][Full Text] [Related]
14. Non-synaptic function of the autism spectrum disorder-associated gene SYNGAP1 in cortical neurogenesis.
Birtele M; Del Dosso A; Xu T; Nguyen T; Wilkinson B; Hosseini N; Nguyen S; Urenda JP; Knight G; Rojas C; Flores I; Atamian A; Moore R; Sharma R; Pirrotte P; Ashton RS; Huang EJ; Rumbaugh G; Coba MP; Quadrato G
Nat Neurosci; 2023 Dec; 26(12):2090-2103. PubMed ID: 37946050
[TBL] [Abstract][Full Text] [Related]
15. Involvement of brain metabolism in neurodevelopmental disorders.
Kotchetkov P; Blakeley N; Lacoste B
Int Rev Neurobiol; 2023; 173():67-113. PubMed ID: 37993180
[TBL] [Abstract][Full Text] [Related]
16.
Trajković J; Makevic V; Pesic M; Pavković-Lučić S; Milojevic S; Cvjetkovic S; Hagerman R; Budimirovic DB; Protic D
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672829
[TBL] [Abstract][Full Text] [Related]
17. Genetic background mutations drive neural circuit hyperconnectivity in a fragile X syndrome model.
Kennedy T; Rinker D; Broadie K
BMC Biol; 2020 Jul; 18(1):94. PubMed ID: 32731855
[TBL] [Abstract][Full Text] [Related]
18. Loss-of-function of KMT5B leads to neurodevelopmental disorder and impairs neuronal development and neurogenesis.
Chen G; Han L; Tan S; Jia X; Wu H; Quan Y; Zhang Q; Yu B; Hu Z; Xia K; Guo H
J Genet Genomics; 2022 Sep; 49(9):881-890. PubMed ID: 35331928
[TBL] [Abstract][Full Text] [Related]
19. Activity-Dependent Remodeling of
Golovin RM; Vest J; Vita DJ; Broadie K
J Neurosci; 2019 Apr; 39(16):2995-3012. PubMed ID: 30755492
[TBL] [Abstract][Full Text] [Related]
20. Disease-Targeted Treatment Translation in Fragile X Syndrome as a Model for Neurodevelopmental Disorders.
Berry-Kravis E
J Child Neurol; 2022 Oct; 37(10-11):797-812. PubMed ID: 35791522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
